2020-2025 Global Diabetes Drugs Market Report - Production and Consumption Professional Analysis
- Report Code : MAI2595115
- Published On: Jul, 2021
- Category : Consumer and general services
- Pages : 119
-
Drugs used in diabetes treat diabetes mellitus by lowering the glucose level in the blood. With the exceptions of insulin, exenatide, liraglutide and pramlintide, all are administered orally and are thus also called oral hypoglycemic agents or oral antihyperglycemic agents. There are different classes of anti-diabetic drugs, and their selection depends on the nature of the diabetes, age and situation of the person, as well as other factors.
This report elaborates the market size, market characteristics, and market growth of the Diabetes Drugs industry, and breaks down according to the type, application, and consumption area of Diabetes Drugs. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Diabetes Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Diabetes Drugs market covered in Chapter 13:
Eli Lilly and Company
Takeda Pharmaceutical Company Limited
Bayer Pharmaceuticals
Boehringer Ingelheim
Novartis
Merck
AstraZeneca
Johnson & Johnson
Sanofi
Novo Nordisk
In Chapter 6, on the basis of types, the Diabetes Drugs market from 2015 to 2025 is primarily split into:
Insulin
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT2 Inhibitors
Others
In Chapter 7, on the basis of applications, the Diabetes Drugs market from 2015 to 2025 covers:
Oral
Subcutaneous
Intravenous
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Diabetes Drugs market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Diabetes Drugs Market - Research Scope1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Diabetes Drugs Market - Research Methodology2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Diabetes Drugs Market Forces3.1 Global Diabetes Drugs Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario3.5 Industry Risk Assessment
4 Diabetes Drugs Market - By Geography4.1 Global Diabetes Drugs Market Value and Market Share by Regions
4.1.1 Global Diabetes Drugs Value ($) by Region (2015-2020)
4.1.2 Global Diabetes Drugs Value Market Share by Regions (2015-2020)4.2 Global Diabetes Drugs Market Production and Market Share by Major Countries
4.2.1 Global Diabetes Drugs Production by Major Countries (2015-2020)
4.2.2 Global Diabetes Drugs Production Market Share by Major Countries (2015-2020)4.3 Global Diabetes Drugs Market Consumption and Market Share by Regions
4.3.1 Global Diabetes Drugs Consumption by Regions (2015-2020)
4.3.2 Global Diabetes Drugs Consumption Market Share by Regions (2015-2020)
5 Diabetes Drugs Market - By Trade Statistics5.1 Global Diabetes Drugs Export and Import
5.2 United States Diabetes Drugs Export and Import (2015-2020)
5.3 Europe Diabetes Drugs Export and Import (2015-2020)
5.4 China Diabetes Drugs Export and Import (2015-2020)
5.5 Japan Diabetes Drugs Export and Import (2015-2020)
5.6 India Diabetes Drugs Export and Import (2015-2020)
5.7
6 Diabetes Drugs Market - By Type6.1 Global Diabetes Drugs Production and Market Share by Types (2015-2020)
6.1.1 Global Diabetes Drugs Production by Types (2015-2020)
6.1.2 Global Diabetes Drugs Production Market Share by Types (2015-2020)6.2 Global Diabetes Drugs Value and Market Share by Types (2015-2020)
6.2.1 Global Diabetes Drugs Value by Types (2015-2020)
6.2.2 Global Diabetes Drugs Value Market Share by Types (2015-2020)6.3 Global Diabetes Drugs Production, Price and Growth Rate of Insulin (2015-2020)
6.4 Global Diabetes Drugs Production, Price and Growth Rate of DPP-4 Inhibitors (2015-2020)
6.5 Global Diabetes Drugs Production, Price and Growth Rate of GLP-1 Receptor Agonists (2015-2020)
6.6 Global Diabetes Drugs Production, Price and Growth Rate of SGLT2 Inhibitors (2015-2020)
6.7 Global Diabetes Drugs Production, Price and Growth Rate of Others (2015-2020)
7 Diabetes Drugs Market - By Application7.1 Global Diabetes Drugs Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Diabetes Drugs Consumption by Applications (2015-2020)
7.1.2 Global Diabetes Drugs Consumption Market Share by Applications (2015-2020)7.2 Global Diabetes Drugs Consumption and Growth Rate of Oral (2015-2020)
7.3 Global Diabetes Drugs Consumption and Growth Rate of Subcutaneous (2015-2020)
7.4 Global Diabetes Drugs Consumption and Growth Rate of Intravenous (2015-2020)
8 North America Diabetes Drugs Market8.1 North America Diabetes Drugs Market Size
8.2 United States Diabetes Drugs Market Size
8.3 Canada Diabetes Drugs Market Size
8.4 Mexico Diabetes Drugs Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Diabetes Drugs Market Analysis9.1 Europe Diabetes Drugs Market Size
9.2 Germany Diabetes Drugs Market Size
9.3 United Kingdom Diabetes Drugs Market Size
9.4 France Diabetes Drugs Market Size
9.5 Italy Diabetes Drugs Market Size
9.6 Spain Diabetes Drugs Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Diabetes Drugs Market Analysis10.1 Asia-Pacific Diabetes Drugs Market Size
10.2 China Diabetes Drugs Market Size
10.3 Japan Diabetes Drugs Market Size
10.4 South Korea Diabetes Drugs Market Size
10.5 Southeast Asia Diabetes Drugs Market Size
10.6 India Diabetes Drugs Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Diabetes Drugs Market Analysis11.1 Middle East and Africa Diabetes Drugs Market Size
11.2 Saudi Arabia Diabetes Drugs Market Size
11.3 UAE Diabetes Drugs Market Size
11.4 South Africa Diabetes Drugs Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Diabetes Drugs Market Analysis12.1 South America Diabetes Drugs Market Size
12.2 Brazil Diabetes Drugs Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Basic Information
13.1.2 Eli Lilly and Company Product Profiles, Application and Specification
13.1.3 Eli Lilly and Company Diabetes Drugs Market Performance (2015-2020)13.2 Takeda Pharmaceutical Company Limited
13.2.1 Takeda Pharmaceutical Company Limited Basic Information
13.2.2 Takeda Pharmaceutical Company Limited Product Profiles, Application and Specification
13.2.3 Takeda Pharmaceutical Company Limited Diabetes Drugs Market Performance (2015-2020)13.3 Bayer Pharmaceuticals
13.3.1 Bayer Pharmaceuticals Basic Information
13.3.2 Bayer Pharmaceuticals Product Profiles, Application and Specification
13.3.3 Bayer Pharmaceuticals Diabetes Drugs Market Performance (2015-2020)13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Basic Information
13.4.2 Boehringer Ingelheim Product Profiles, Application and Specification
13.4.3 Boehringer Ingelheim Diabetes Drugs Market Performance (2015-2020)13.5 Novartis
13.5.1 Novartis Basic Information
13.5.2 Novartis Product Profiles, Application and Specification
13.5.3 Novartis Diabetes Drugs Market Performance (2015-2020)13.6 Merck
13.6.1 Merck Basic Information
13.6.2 Merck Product Profiles, Application and Specification
13.6.3 Merck Diabetes Drugs Market Performance (2015-2020)
13.7 AstraZeneca
13.7.1 AstraZeneca Basic Information
13.7.2 AstraZeneca Product Profiles, Application and Specification
13.7.3 AstraZeneca Diabetes Drugs Market Performance (2015-2020)
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Basic Information
13.8.2 Johnson & Johnson Product Profiles, Application and Specification
13.8.3 Johnson & Johnson Diabetes Drugs Market Performance (2015-2020)
13.9 Sanofi
13.9.1 Sanofi Basic Information
13.9.2 Sanofi Product Profiles, Application and Specification
13.9.3 Sanofi Diabetes Drugs Market Performance (2015-2020)13.10 Novo Nordisk
13.10.1 Novo Nordisk Basic Information
13.10.2 Novo Nordisk Product Profiles, Application and Specification
13.10.3 Novo Nordisk Diabetes Drugs Market Performance (2015-2020)
14 Market Forecast - By Regions14.1 North America Diabetes Drugs Market Forecast (2020-2025)
14.2 Europe Diabetes Drugs Market Forecast (2020-2025)
14.3 Asia-Pacific Diabetes Drugs Market Forecast (2020-2025)
14.4 Middle East and Africa Diabetes Drugs Market Forecast (2020-2025)
14.5 South America Diabetes Drugs Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications15.1 Global Diabetes Drugs Market Forecast by Types (2020-2025)
15.1.1 Global Diabetes Drugs Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Diabetes Drugs Market Forecast Value and Market Share by Types (2020-2025)15.2 Global Diabetes Drugs Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Diabetes Drugs Picture
Table Diabetes Drugs Key Market Segments
Figure Study and Forecasting Years
Figure Global Diabetes Drugs Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Diabetes Drugs Value ($) and Growth Rate (2015-2020)
Table Global Diabetes Drugs Value ($) by Countries (2015-2020)
Table Global Diabetes Drugs Value Market Share by Regions (2015-2020)
Figure Global Diabetes Drugs Value Market Share by Regions in 2019
Figure Global Diabetes Drugs Production and Growth Rate (2015-2020)
Table Global Diabetes Drugs Production by Major Countries (2015-2020)
Table Global Diabetes Drugs Production Market Share by Major Countries (2015-2020)
Figure Global Diabetes Drugs Production Market Share by Regions in 2019
Figure Global Diabetes Drugs Consumption and Growth Rate (2015-2020)
Table Global Diabetes Drugs Consumption by Regions (2015-2020)
Table Global Diabetes Drugs Consumption Market Share by Regions (2015-2020)
Figure Global Diabetes Drugs Consumption Market Share by Regions in 2019
Table Global Diabetes Drugs Export Top 3 Country 2019
Table Global Diabetes Drugs Import Top 3 Country 2019
Table United States Diabetes Drugs Export and Import (2015-2020)
Table Europe Diabetes Drugs Export and Import (2015-2020)
Table China Diabetes Drugs Export and Import (2015-2020)
Table Japan Diabetes Drugs Export and Import (2015-2020)
Table India Diabetes Drugs Export and Import (2015-2020)
Table Global Diabetes Drugs Production by Types (2015-2020)
Table Global Diabetes Drugs Production Market Share by Types (2015-2020)
Figure Global Diabetes Drugs Production Share by Type (2015-2020)
Table Global Diabetes Drugs Value by Types (2015-2020)
Table Global Diabetes Drugs Value Market Share by Types (2015-2020)
Figure Global Diabetes Drugs Value Share by Type (2015-2020)
Figure Global Insulin Production and Growth Rate (2015-2020)
Figure Global Insulin Price (2015-2020)
Figure Global DPP-4 Inhibitors Production and Growth Rate (2015-2020)
Figure Global DPP-4 Inhibitors Price (2015-2020)
Figure Global GLP-1 Receptor Agonists Production and Growth Rate (2015-2020)
Figure Global GLP-1 Receptor Agonists Price (2015-2020)
Figure Global SGLT2 Inhibitors Production and Growth Rate (2015-2020)
Figure Global SGLT2 Inhibitors Price (2015-2020)
Figure Global Others Production and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Diabetes Drugs Consumption by Applications (2015-2020)
Table Global Diabetes Drugs Consumption Market Share by Applications (2015-2020)
Figure Global Diabetes Drugs Consumption Share by Application (2015-2020)
Figure Global Oral Consumption and Growth Rate (2015-2020)
Figure Global Subcutaneous Consumption and Growth Rate (2015-2020)
Figure Global Intravenous Consumption and Growth Rate (2015-2020)
Figure North America Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Table North America Diabetes Drugs Consumption by Countries (2015-2020)
Table North America Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure North America Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure United States Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure Canada Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure Mexico Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Table Europe Diabetes Drugs Consumption by Countries (2015-2020)
Table Europe Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure Europe Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure Germany Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure France Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure Italy Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure Spain Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Diabetes Drugs Consumption by Countries (2015-2020)
Table Asia-Pacific Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure China Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure Japan Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Korea Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure India Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Diabetes Drugs Consumption by Countries (2015-2020)
Table Middle East and Africa Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure UAE Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure South Africa Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Figure South America Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Table South America Diabetes Drugs Consumption by Countries (2015-2020)
Table South America Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure South America Diabetes Drugs Consumption Market Share by Countries (2015-2020)
Figure Brazil Diabetes Drugs Market Consumption and Growth Rate (2015-2020)
Table Eli Lilly and Company Company Profile
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2015-2020
Table Takeda Pharmaceutical Company Limited Company Profile
Table Takeda Pharmaceutical Company Limited Production, Value, Price, Gross Margin 2015-2020
Figure Takeda Pharmaceutical Company Limited Production and Growth Rate
Figure Takeda Pharmaceutical Company Limited Value ($) Market Share 2015-2020
Table Bayer Pharmaceuticals Company Profile
Table Bayer Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Bayer Pharmaceuticals Production and Growth Rate
Figure Bayer Pharmaceuticals Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Novartis Company Profile
Table Novartis Production, Value, Price, Gross Margin 2015-2020
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Table Merck Company Profile
Table Merck Production, Value, Price, Gross Margin 2015-2020
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table AstraZeneca Company Profile
Table AstraZeneca Production, Value, Price, Gross Margin 2015-2020
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Sanofi Company Profile
Table Sanofi Production, Value, Price, Gross Margin 2015-2020
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2015-2020
Table Novo Nordisk Company Profile
Table Novo Nordisk Production, Value, Price, Gross Margin 2015-2020
Figure Novo Nordisk Production and Growth Rate
Figure Novo Nordisk Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Diabetes Drugs Market Forecast Production by Types (2020-2025)
Table Global Diabetes Drugs Market Forecast Production Share by Types (2020-2025)
Table Global Diabetes Drugs Market Forecast Value ($) by Types (2020-2025)
Table Global Diabetes Drugs Market Forecast Value Share by Types (2020-2025)
Table Global Diabetes Drugs Market Forecast Consumption by Applications (2020-2025)
Table Global Diabetes Drugs Market Forecast Consumption Share by Applications (2020-2025)
-
The Global Diabetes Drugs Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
The flow of investment into the Global Diabetes Drugs Market, which is utilizing technologies to drive efficiency and high volume, clearly shows the market opportunity.
In recent years, the Global Diabetes Drugs Market has grown at an incredible rate. From 2024 to 2029, the market is expected to grow at a CAGR of yy%.
The influx of capital into the Global Diabetes Drugs Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
The majority of data for the Global Diabetes Drugs Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.
